[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sanofi (SNY)
US FDA launches fresh safety scrutiny of approved RSV therapies for infants, while Sanofi's Blueprint Medicines highlights long-term clinical benefit of AYVAKIT.
About Sanofi
Sanofi is a global pharmaceutical company.
Sanofi uses the ticker $SNY for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Sanofi (SNY) social dominance hit XXXXX which is XXX% higher than it's daily average.
- Sanofi (SNY) market dominance near a 52-week low at XXXXXXX.
- Sanofi (SNY) trading volume is up XXXXX% from the previous week.
- Sanofi (SNY) social dominance is up XXXXXX% from the previous X months.
- Sanofi (SNY) Galaxy Score™ is up XX% from the previous X months.
- Sanofi (SNY) engagements is up XXXXX% from the previous week.
- Sanofi (SNY) posts created is up XXXXX% from the previous week.
Price: $XXXXX
Price 24-Hour Time-Series Raw Data
Sanofi's stock price is experiencing downward pressure, likely influenced by the ongoing tax fraud investigation and headquarters raid, which appears to be outweighing positive news regarding Dupixent sales and EU approval.
24-Hour: XXXX% 7-Day: -XXXX% 30-Day: -XXXX%
1-Year High: $XXXXX on 2025-03-06
1-Year Low: $XXXXX on 2025-09-25
AltRank: XXX
AltRank 24-Hour Time-Series Raw Data
Sanofi (SNY) is currently AltRank #149 based on combined combined social and market metrics
Daily Average: XXXXX
X Week: XXX +31
X Month: XXX -XXX
X Months: XXX -XXXXX
X Year: XXX -XXXXX
1-Year High: XXXXX on 2025-07-06
1-Year Low: XX on 2025-09-05
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +25
X Month: XX +15
X Year: XX +33
1-Year High: XX on 2025-12-12
1-Year Low: XX on 2025-09-24
Engagements: XXXXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXXX
Daily Average: XXXXXXX
X Week: XXXXXXXXX +41%
X Month: XXXXXXXXX +8.10%
X Months: XXXXXXXXXX +197%
X Year: XXXXXXXXXX -XX%
1-Year High: XXXXXXXXX on 2025-11-01
1-Year Low: XXXXX on 2025-02-02
Engagements by network (24h): News: XX Reddit: XXX TikTok: XXXXX X: XXXXXXX YouTube: XXXXXXX
Mentions: XXX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXXXX -XXXX%
X Month: XXXXX -XX%
X Months: XXXXXX +80%
X Year: XXXXXX +61%
1-Year High: XXXXX on 2025-08-07
1-Year Low: XXX on 2025-01-27
Mentions by network (24h): News: XX Reddit: XX TikTok: XXX X: XXXXX YouTube: XXX
Creators: XXX (24h)
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Sanofi (SNY) in the last XX hours which is up XX% from XXX in the previous XX hours
Daily Average: XXX
X Week: XXX -XX%
X Month: XXXXX -XX%
X Months: XXXXX +71%
X Year: XXXXX +36%
1-Year High: XXX on 2025-09-04
1-Year Low: XX on 2025-01-27
The most influential creators that mention Sanofi in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @laurogeitabat | X | XXXXX | X | XXXXXXX |
| @sanofi | X | XXXXXX | XX | XXXXXXX |
| @smithy05261244 | X | XXX | X | XXXXXX |
| @HOThomasWPhelps | X | XXXXX | X | XXXXX |
| @PCM_bio | X | XXXXX | X | XXXXX |
| @BowTiedBiotech | X | XXXXXX | X | XXXXX |
| @physioo | X | XXX | X | XXXXX |
| @yaireinhorn | X | XXXXXX | X | XXXXX |
| @BigChodu | X | XXXXX | X | XXX |
| @grok | XX | XXXXXXXXX | XX | XXX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +2%
X Month: XX% +11%
X Months: XX% +11%
X Year: XX% +3%
1-Year High: XX% on 2025-11-02
1-Year Low: XX% on 2025-08-02
Most Supportive Themes:
- Dupixent Sales Driving Growth: (20%) Sanofi's drug Dupixent is a significant revenue driver, nearing $X billion in sales, indicating strong market performance and product success.
- India Market Expansion: (15%) Sanofi is actively expanding its presence in India through new product launches and strategic portfolio development, signaling a focus on emerging markets.
- Partnerships and Acquisitions: (10%) The company is engaging in strategic partnerships, such as with Novavax, and exploring potential acquisitions, demonstrating a proactive approach to growth and innovation.
Most Critical Themes:
- Vaccine Concerns: (5%) Despite overall positive financial results, Sanofi is facing some negative sentiment or 'buzz' surrounding its vaccine products.
- Potential Acquisition Targets: (5%) Discussions around potential acquisitions, like Abgenix, suggest strategic shifts or potential divestitures that could impact the company's future.
Social Dominance: XXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.078%
X Month: XXXXX% +0.237%
X Months: XXXXX% +0.265%
X Year: XXXXX% +0.25%
1-Year High: XXXXX% on 2025-12-12
1-Year Low: XXXXX% on 2025-04-07
Market Dominance: XXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXX% on 2025-03-31
1-Year Low: XXXXX% on 2025-09-25
Market Cap: $XXXXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXXX -$0.03%
X Month: $XXXXXXXXXXXXXXX -$5.50%
X Months: $XXXXXXXXXXXXXXX -$1.90%
X Year: $XXXXXXXXXXXXXXX -$1.40%
1-Year High: $XXXXXXXXXXXXXXX on 2025-03-06
1-Year Low: $XXXXXXXXXXXXXXX on 2025-09-25
Top Sanofi News
Top news links shared on social in the last XX hours
Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.
"US FDA launches fresh safety scrutiny of approved RSV therapies for infants CNN"
News Link @CNN 2025-12-09T22:02Z 60.9M followers, XXX engagements
"Blueprint Medicines a Sanofi Company Highlights Long-Term Clinical Benefit of AYVAKIT (avapritinib) Across Indolent and Advanced Systemic Mastocytosis at 2025 ASH Annual Meeting"
News Link @PRNewswire 2025-12-05T13:06Z 228.6M followers, 4431 engagements
"Notable healthcare headlines for the week: Sanofi Eli Lilly and Novo Nordisk in focus Seeking Alpha"
News Link @SeekingAlpha 2025-11-30T16:45Z 228.6M followers, 2315 engagements
Top Sanofi Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@OopsGuess @Megatron_ron In addition to Airbus LVMH (luxury goods) Sanofi (pharmaceuticals) EDF (nuclear power plant) Alstom (high speed rail) Schneider Electric (SCADA/industrial automation) etc"
X Link @Phil_S_Park 2025-12-11T17:26Z XXX followers, XXX engagements
": The leaders of London based @labgeni_us discuss a recent ESMO IO poster for their Nectin-4 x CD3 T-cell engager and a new expanded collaboration with Sanofi on antibody optimization. Full video:"
X Link @BiotechTV 2025-12-11T17:06Z 9912 followers, XXX engagements
"All those #SuperFlu (#H3N2 actually) news in #UK circulating for last X days are sponsored by : @sanofi @AstraZeneca CSL Seqirus UK. @ViatrisInc Thank you for Paying Attention Yours Truly #VaccineNewsMafia"
X Link @shuvankr 2025-12-11T16:51Z 4066 followers, XXX engagements
"$OODH - Orion Expands Rare Earth and Critical-Mineral Holdings With New Nevada Lease; Provides Update on Multi-State Energy Operations $PG $MRK $MYL $VRTX $BIIB $BMY $JNJ $AZN $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS $WBA $RAD $HLF $CJJD $GNC $DPLO"
X Link @MoneyMaker0009 2025-12-11T16:41Z XXX followers, XXX engagements